Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Gilead Expects HIV Revenue to Grow About 12% in 2026

By Public Technologies
  • Gilead expects fiscal 2026 HIV revenue growth of about 12%, with Yeztugo revenue forecast at approximately $1 billion.
  • Third-quarter HIV sales rose 18% to $6.2 billion, supporting the outlook.
  • Cell therapy revenue is expected to decline by a mid-teens percentage in 2026 amid competitive headwinds; Veklury revenue should total approximately $300 million.
  • Medicare pricing changes are projected to reduce Biktarvy revenue by approximately $1.5 billion in 2028 versus 2027, including spillover into other payer channels.
  • Biktarvy’s Medicare price will be $2,600 per 30-day supply starting January 1, 2028, approximately 38% below list price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief on November 14, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.